Synthesis of water-soluble dendrimers based on melamine bearing 16 paclitaxel groups.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Organic Letters

• Publication date

  2008-01-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/OL7024907PMID 18088131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization.

  2007cited by this paper
• The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.

  2006cited by this paper
• PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

  2006cited by this paper
• Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics.

  2006cited by this paper
• Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.

  2006cited by this paper
• A divergent route to diversity in macromolecules.

  2006cited by this paper
• Toward the next-generation drug delivery vehicle: synthesis of a dendrimer with four orthogonally reactive groups.

  2005cited by this paper
• Synthesis and evaluation of a star amphiphilic block copolymer from poly(epsilon-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier.

  2005cited by this paper
• Core-cross-linked polymeric micelles as paclitaxel carriers.

  2004cited by this paper
• Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.

  2004cited by this paper
• Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery.

  2004cited by this paper
• Synthesis and manipulation of orthogonally protected dendrimers: building blocks for library synthesis.

  2004cited by this paper
• Hydrotropic dendrimers of generations 4 and 5: synthesis, characterization, and hydrotropic solubilization of paclitaxel.

  2004cited by this paper
• Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)- propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft- poly(L-lactic acid): a novel carrier for transmucosal delivery of peptides.

  2004cited by this paper
• The dawning era of polymer therapeutics

  2003cited by this paper
• Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.

  2003cited by this paper
• Evaluation of multivalent dendrimers based on melamine: kinetics of thiol-disulfide exchange depends on the structure of the dendrimer.

  2003cited by this paper
• Chemoselective building blocks for dendrimers from relative reactivity data.

  2003cited by this paper
• A folate receptor-targeted emulsion formulation for paclitaxel.

  2003cited by this paper
• Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture.

  2002cited by this paper
• Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor

  2002cited by this paper
• Molecular structure of single DNA complexes with positively charged dendronized polymers.

  2002cited by this paper
• Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy.

  2002cited by this paper
• Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.

  2001cited by this paper
• Convergent dendrons and dendrimers: from synthesis to applications.

  2001cited by this paper
• Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors.

  2000cited by this paper
• Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel.

  2000cited by this paper
• The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents.

  1997cited by this paper
• Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.

  1989cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

  1973cited by this paper

• Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions

  2025cites this paper
• Columnar Liquid-Crystalline Triazine-Based Dendrimer with Carbon Nanotube Filler for Efficient Organic Lithium-Ion Batteries

  2022cites this paper
• Two Decades of Triazine Dendrimers

  2021cites this paper
• Surface-engineered dendrimers in targeting and delivery of drugs

  2021cites this paper
• Polymeric nanocarriers: A promising tool for early diagnosis and efficient treatment of colorectal cancer

  2021cites this paper
• A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment

  2020cites this paper
• Understanding the pharmaceutical aspects of dendrimers for the delivery of anticancer drugs.

  2020cites this paper
• Hydrophilic triazine-based dendron for copper and lead adsorption in aqueous systems: Performance and mechanism

  2020cites this paper
• Dendrimers

  2019cites this paper
• Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting

  2019cites this paper
• Dendrimers in combination with natural products and analogues as anti-cancer agents.

  2018cites this paper
• Nanoreactors for green catalysis

  2018cites this paper
• Fluorescent Dendritic Micro-Hydrogels: Synthesis, Analysis and Use in Single-Cell Detection

  2018cites this paper
• Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.

  2017cites this paper
• Multifunctional Homopolymers: Postpolymerization Modification via Sequential Nucleophilic Aromatic Substitution

  2016cites this paper
• Prodrug Strategies for Paclitaxel

  2016cites this paper
• Converting Nonliquid Crystals into Liquid Crystals by N-Methylation in the Central Linker of Triazine-Based Dendrimers.

  2016cites this paper
• Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses

  2016cites this paper
• Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

  2015cites this paper
• Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges.

  2015cites this paper
• Polyphosphoester‐based paclitaxel complexes

  2015cites this paper
• An Unconventional Approach to Induce Liquid-Crystalline Phases of Triazine-Based Dendrons by Breaking Their Self-Assembly into Dimers.

  2015cites this paper
• Dendrimer-drug Conjugates in Drug Delivery and Targeting

  2015cites this paper
• Triazine Dendrimers: Biomedical Application

  2015cites this paper
• Efficient and Chemoselective Synthesis of ω,ω-Heterodifunctional Polymers.

  2015cites this paper
• A small change in central linker has a profound effect in inducing columnar phases of triazine-based unconventional dendrimers.

  2014cites this paper
• Dendrimers for drug delivery.

  2014cites this paper
• Dendrimer Bioconjugates: Synthesis and Applications

  2014cites this paper
• Taxane conjugate nanoparticles for improved non-small cell lung cancer treatment in a novel orthotopic mouse model

  2014cites this paper
• Conception, synthèse et caractérisation de nouvelles macromolécules branchées biocompatibles pour encapsuler des principes actifs hydrophobes

  2014cites this paper
• A critical review of lipid-based nanoparticles for taxane delivery.

  2013cites this paper
• Dendrimers as macromolecular tools to tackle from colon to brain tumor types: a concise overview

  2013cites this paper
• Application of polymer drugs to medical devices and reparative medicine

  2013cites this paper
• Computational design principles for the discovery of bioactive dendrimers: [s]-triazines and other examples

  2013cites this paper
• Design, synthesis and biological assessment of a triazine dendrimer with approximately 16 Paclitaxel groups and 8 PEG groups.

  2013cites this paper
• Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.

  2013cites this paper
• Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation.

  2012cites this paper
• Induction of the columnar phase of unconventional dendrimers by breaking the C2 symmetry of molecules.

  2012cites this paper
• Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.

  2012cites this paper
• Triazine dendrimers as drug delivery systems: from synthesis to therapy.

  2012cites this paper
• Formation of columnar liquid crystals on the basis of unconventional triazine-based dendrimers by the C3-symmetric approach.

  2012cites this paper
• A versatile thiouronium-based solid-phase synthesis of 1,3,5-triazines.

  2012cites this paper
• Paclitaxel-Triazine Dendrimer Constructs: Efficacy, Toxicity, and Characterization

  2012cites this paper
• Cytotoxicity of PAMAM, PPI and maltose modified PPI dendrimers in Chinese hamster ovary (CHO) and human ovarian carcinoma (SKOV3) cells

  2012cites this paper
• Dendrimers : Properties and Applications

  2012cites this paper
• Dendrimer therapeutics: covalent and ionic attachments

  2012cites this paper
• Facile Synthesis of Dendritic Hydroxyl-terminated Cyanuric Chloride Derivatives and Their Properties

  2012cites this paper
• Therapeutic applications of engineered nanomaterials

  2012cites this paper
• Degradable Dendrimers for Drug Delivery

  2012cites this paper
• Dendrimer‐Based Prodrugs: Synthesis and Biological Evaluation

  2012cites this paper
• Biomedical applications of dendrimers: a tutorial.

  2011cites this paper
• Medicinal Chemistry of α‐Hydroxy‐β‐Amino Acids

  2011cites this paper
• Efficient and Complementary Methods Offering Access to Synthetically Valuable 1,2‐Dibromobenzenes

  2011cites this paper
• A synthetic "tour de force": well-defined multivalent and multimodal dendritic structures for biomedical applications.

  2011cites this paper
• Sequential functionalization of janus‐type dendrimer‐like poly(ethylene oxide)s with camptothecin and folic acid

  2011cites this paper
• Chemotherapeutic Evaluation of a Synthetic Tubulysin Analogue–Dendrimer Conjugate in C26 Tumor Bearing Mice

  2011cites this paper
• Macromolecules as taxane delivery systems

  2011cites this paper
• Biological Assessment of Triazine Dendrimers as Candidate Platforms for Nanomedicine: Toxicological Profiles, Solution Behavior, Biodistribution, and Drug Release and Efficacy in a PEGylated, Paclitaxel Construct

  2011cites this paper
• Ein Meisterstück in der Synthese: wohldefinierte, multivalente und multimodale dendritische Architekturen für biomedizinische Anwendungen

  2011cites this paper
• Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct.

  2010cites this paper
• Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.

  2010cites this paper
• Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine.

  2010cites this paper
• Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer.

  2010cites this paper
• Development and characterization of triazine based dendrimers for delivery of antitumor agent.

  2010cites this paper
• Tobacco mosaic virus based thin film sensor for detection of volatile organic compounds

  2010cites this paper
• The 8 year thicket of triazine dendrimers: strategies, targets and applications

  2010cites this paper
• Dendrimer toxicity: Let's meet the challenge.

  2010cites this paper
• Microwave-assisted synthesis of pyrazolyl bistriazines

  2010cites this paper
• Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.

  2010cites this paper
• New challenges in nanotechnology: the use of dendrimers in drug administration

  2009cites this paper
• Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages.

  2009cites this paper
• Dendrimers as versatile platform in drug delivery applications.

  2009cites this paper
• Chapter 4 – Four-membered ring systems

  2009cites this paper
• SYNTHESIS OF 2-[3,3'-DI-(TERT-BUTOXYCARBONYL)-AMINODIPROPYLAMINE]-4,6,-DICHLORO-1,3,5-TRIAZINE AS A MONOMER AND 1,3,5-[TRIS-PIPERAZINE]-TRIAZINE AS A CORE FOR THE LARGE SCALE SYNTHESIS OF MELAMINE (TRIAZINE) DENDRIMERS.

  2009cites this paper
• Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles.

  2009cites this paper
• Site‐specific and Spatially Controlled Addressability of a New Viral Nanobuilding Block: Sulfolobus islandicus Rod‐shaped Virus 2

  2008cites this paper
• Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates†

  2008cites this paper